Top Story

Proton beam therapy shows promise for non-small cell lung cancer

Proton beam therapy shows promise for non-small cell lung cancer
July 20, 2017

Proton beam radiotherapy with concurrent chemoradiotherapy appeared safe and effective among patients with advanced non-small cell lung cancer, according to results of a phase 2 prospective study.

“This is first and only study with 5 years survival of concurrent chemotherapy and proton therapy in inoperable stage III NSCLC,” Joe Y. Chang, MD, PhD, professor of radiation oncology at The University of Texas MD Anderson Cancer Center, told HemOnc Today. “[Proton beam radiotherapy] had a great potential to treat lung cancer. However, the technology is still improving and better result will be achieved in near future.”

FDA hosts public forum on reform for generics regulations, approvals

July 19, 2017
To ensure the intended balance between encouraging innovation in drug development and accelerating the availability of lower cost alternatives to innovator drugs, the…

AMA: Health care debate ‘by no means over’

July 18, 2017
While a series of announcements by Senate Republicans seem to indicate that for the time being attempts both to replace and repeal the ACA have stalled, AMA president…

AMA, ACP, AAFP applaud CMS update of physician fee schedule

July 18, 2017
In its response to the physician fee schedule proposed rule released by CMS, the AMA noted numerous positive changes that have the potential to improve patient care and…
More News Headlines »
CME Article

Pulmonary Complications of Pediatric Neurological Diseases

Pediatric Annals, April 2010, Volume 39 Issue 4
Significant pulmonary compromise is associated with a spectrum of neurological diseases in the pediatric population…
More »
Meeting News

VIDEO: HR experts tackle hot topics from immigration to Generation Z

March 1, 2017
More »